Abstract
Tools for artificial intelligence and data mining can derive (Quantitative) Structure-Activity Relationships ((Q)SARs) for toxicity in an objective and reproducible manner. This review provides a conceptual description of the most important data mining algorithms for the identification of chemical features and the extraction of relationships between these descriptors and toxic activities. We will discuss the compliance of these techniques with the OECD guidelines for (Q)SAR requirements as well as performance implications. Special emphasis will be given to validation procedures for (Q)SAR models.
Keywords: Predictive toxicology, QSAR, artificial intelligence, data mining, machine learning, pattern recognition, datadriven, learning, chemoinformatics
Current Computer-Aided Drug Design
Title: Artificial Intelligence and Data Mining for Toxicity Prediction
Volume: 2 Issue: 2
Author(s): Christoph Helma and Jeroen Kazius
Affiliation:
Keywords: Predictive toxicology, QSAR, artificial intelligence, data mining, machine learning, pattern recognition, datadriven, learning, chemoinformatics
Abstract: Tools for artificial intelligence and data mining can derive (Quantitative) Structure-Activity Relationships ((Q)SARs) for toxicity in an objective and reproducible manner. This review provides a conceptual description of the most important data mining algorithms for the identification of chemical features and the extraction of relationships between these descriptors and toxic activities. We will discuss the compliance of these techniques with the OECD guidelines for (Q)SAR requirements as well as performance implications. Special emphasis will be given to validation procedures for (Q)SAR models.
Export Options
About this article
Cite this article as:
Helma Christoph and Kazius Jeroen, Artificial Intelligence and Data Mining for Toxicity Prediction, Current Computer-Aided Drug Design 2006; 2 (2) . https://dx.doi.org/10.2174/157340906777441717
DOI https://dx.doi.org/10.2174/157340906777441717 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
Call for Papers in Thematic Issues
Artificial Intelligence in Biomedical Research: Enhancing Data Analysis for Drug Discovery and Development
This thematic issue highlights the transformative impact of Artificial Intelligence (AI), with a particular focus on Machine Learning (ML) and Deep Learning (DL) techniques, in advancing biomedical research. As a result of these cutting-edge AI methodologies, drug discovery and development are revolutionizing data analysis. Rapid advances in artificial intelligence technologies ...read more
Computer-Aided Drug Discoveries for Emerging Diseases
Computer-aided drug design is a rapidly growing research field that continues to gain momentum, attracting increasing interest from the scientific community. This trend is largely driven by the growing utilization of machine learning and artificial intelligence in drug design and discovery. Artificial Intelligence has proven efficacy across various applications, including ...read more
Deep Learning Approaches in Bioinformatics for Computer-Aided Drug Development Targeting Brain Tumors
The integration of deep learning and bioinformatics is revolutionizing the field of computer-aided drug development, particularly in the fight against brain tumors one of the most aggressive and lethal types of cancer. Brain tumors present significant challenges due to their heterogeneity and complexity, which require novel approaches for early diagnosis ...read more
Emerging Trends in Computer-Aided Drug and Healthcare Solutions
This special issue aims to further the advancement of knowledge in drug design, healthcare innovations, and medical solutions by leveraging modern computational techniques. In recent years, computer-aided drug design has transformed the approach to medicinal chemistry, accelerating the drug discovery process and fostering innovation. The goal of this issue is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Virus-Like Particles as Particulate Vaccines
Current HIV Research Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected Diseases
Current Topics in Medicinal Chemistry Bisthiourea Derivatives of Dipeptide Conjugated Benzo[d]isoxazole as a New Class of Therapeutics: Synthesis and Molecular Docking Studies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry <i>Bis</i>-1,3,4-Oxadiazole Derivatives as Novel and Potential Urease Inhibitors; Synthesis, <i>In Vitro</i>, and <i>In Silico</i> Studies
Medicinal Chemistry Impact of COVID-19 on Mental Dimension of Health: A Sensitive Issue to be Addressed at the Earliest
Current Psychiatry Research and Reviews Diagnostic Value of Chest CT in Coronavirus Disease 2019 (COVID-19)
Current Medical Imaging Stimuli-sensitive Chitosan-based Nanosystems-immobilized Nucleic Acids for Gene Therapy in Breast Cancer and Hepatocellular Carcinoma
Current Topics in Medicinal Chemistry Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study
Anti-Cancer Agents in Medicinal Chemistry Thymosin α1; Potential Therapeutic Implications of an Immunoregulatory Drug in the Treatment of Lymphocytopenia Associated with COVID-19
Current Immunology Reviews (Discontinued) TRPV4 Agonists and Antagonists
Current Topics in Medicinal Chemistry Remdesivir, A Potential Drug for COVID-19 Treatment: A New Hope
Coronaviruses Discovery and Development of ATP-Competitive mTOR Inhibitors Using Computational Approaches
Current Pharmaceutical Design Cold Non-equilibrium Plasma as a Tool for Air Disinfection and Destruction of Biological Objects
Current Biotechnology Malaria-induced Alterations of Drug Kinetics and Metabolism in Rodents and Humans
Current Drug Metabolism ATP Citrate Lyase Inhibitors as Novel Cancer Therapeutic Agents
Recent Patents on Anti-Cancer Drug Discovery Multifunctional Nanomedicine Platform for Cancer Specific Delivery of siRNA by Superparamagnetic Iron Oxide Nanoparticles-Dendrimer Complexes
Current Drug Delivery An Overview of Acute Flaccid Myelitis
CNS & Neurological Disorders - Drug Targets Prediction of Rhizoma Drynariae Targets in the Treatment of Osteonecrosis of the Femoral Head based on Network Pharmacology and Experimental Verification
Current Computer-Aided Drug Design Novel Concepts in the Management of Angina in Coronary Artery Disease
Current Pharmaceutical Design Recent Developments of C-Aryl Glucoside SGLT2 Inhibitors
Current Medicinal Chemistry